GSK Director PDMR Shareholding Disclosed via RNS Filing
GSK plc submitted an RNS announcement on 26 August 2026 covering a Director/PDMR shareholding disclosure. The filing is provided through the London Stock Exchange’s RNS service, which is approved by the UK Financial Conduct Authority as a Primary Information Provider. The announcement includes the company’s public purpose statement but no other operational or policy change details.